Your session is about to expire
← Back to Search
Temporo-masseteric Nerve Block Administration for Blockage
Study Summary
This trial will test a new injection for TMJ pain in 20 people. Outcomes will be measured by force and electrical activity in the jaw muscles, and participants will be surveyed about their experience.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently undergoing orthodontic treatment.I have had a recent injury or surgery on my face or jaw within the last 6 months.I am either male or female.I have heart disease or heart failure.I have never been diagnosed with TMD.I am on dialysis or have kidney failure.I have a history of seizures, thyroid issues, substance abuse, or psychiatric conditions.I don't have a history of significant face or mouth pain.I do not have uncontrolled breathing problems, high blood pressure, or diabetes.I've had fewer than 5 headaches a month in the last 3 months.I have not experienced jaw or temple pain, stiffness, or discomfort in the last 30 days.I am between 18 and 64 years old.
Frequently Asked Questions
What are the odds of experiencing side effects from this medication?
"While Phase 2 trials do not have the same level of data supporting efficacy, this treatment received a score of 2 for safety."
How many study participants are needed for this clinical trial?
"Yes, that is correct. The information available on clinicaltrials.gov makes it clear that this study is still looking for patients to enroll. 20 individuals are needed in total from 1 medical facility, and the trial was originally posted on October 10th, 2022 with a recent update on the 24th of October."
Are individuals outside of the age range of 50 being recruited for this experiment?
"Eligibility for this study requires that potential participants are aged between 18 and 64 years old."
Would I be a good candidate to join this clinical study?
"Eligible patients for this clinical trial will have occlusion and be between 18-64 years old. Up to 20 participants can take part in the study."
Are researchers looking for more participants in this trial?
"Indeed, the clinicaltrials.gov website contains information suggesting that this study is actively recruiting patients as of 10/24/2022. 20 individuals are needed for the trial which is set to take place at a single location."
Share this study with friends
Copy Link
Messenger